Earlier this week, we published an article on Mydecine Innovations Group ($MYCO) and their recent changes, developments, and pivots.

Following that publication, our very own Charley Rose sat down with the CEO of Mydecine, Josh Bartch.

During the interview, Charley does a deep dive into the company and its current positioning in the market. For those that were still looking for more information on the company, this interview will shed the light you’re looking for.

Browse More Videos on our YouTube Channel

If you’d like to watch more interviews like this one, head over to our YouTube channel and like and subscribe. We release daily content as we continue to provide analyses and insights on the psychedelics market and industry as a whole.